MNDL Bio
About
MNDL Bio is a synthetic biology company focused on reducing the cost and production time for food and biotechnology applications. They achieve this through advanced computational platforms designed to optimize gene expression, enabling more efficient and scalable biological manufacturing.
Key facts
At-a-glance profile data
- Website
- mndl.bio
- Headquarters
- San Francisco, United States
- Founded
- 2023
- Employees
- 10
- Total funding
- $2M (Pre-Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 8 Sept 2024 | Pre-Seed | $2M | Earth & Beyond Ventures, Israel Innovation Authority |
Tech stack
Detected on mndl.bio, last scanned 19 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has MNDL Bio raised?
MNDL Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
How many employees does MNDL Bio have?
MNDL Bio has approximately 10 people on record.